About Us
Forest Hills Lab (FHL) is composed of two divisions: the Therapeutics division and the Aesthetics division. Our global network spans offices in the United States, Singapore, South Korea and Hong Kong, where we are headquartered.
%20-%20Copy_e.jpg)
FHL Therapeutics
​A clinical stage, biopharmaceutical advancing a multi-modal pipeline of seven potentially disease-modifying neurological assets, initially targeting Alzheimer’s and Parkinson’s disease.
FHL Aesthetics
Deep-rooted in American culture and technology, FHL Aesthetics develops and markets a comprehensive line of medical- and non-medical-grade aesthetics products globally with Korean R&D and manufacturing excellence.
%20-%20Copy_e.jpg)
%20-%20Copy_edited.jpg)
Mstone Healthcare Partners
FHL’s controlling shareholder is Mstone Healthcare Partners, an entrepreneurial incubator building aesthetics and healthcare, life sciences, and AI-related companies. Mstone founds, staffs, develops, and grows portfolio companies by building upon novel technology as well as human and investment capital.